Updated on 29 October 2026
Seeking collaboration on novel small-molecule antiviral therapeutics – Horizon Europe Health
Grant Manager at Ignaz Semmelweis Institute
WIEN, Austria
About
The Ignaz Semmelweis Institute (Medical University of Vienna) is seeking collaboration opportunities for the upcoming Horizon Europe Health call on the development of novel small-molecule antiviral therapeutics.
We offer complementary expertise in:
-
Virology and emerging pathogens: Hantaviruses (including Andes virus), other high-priority viral pathogens, virus–host interactions, and viral immunology.
-
Advanced infection models: Human-relevant 3D and organoid models, respiratory barrier systems, and innovative infection models.
-
Innate immunity and host responses: Antiviral immune mechanisms, monocyte/macrophage biology, and immunoprofiling.
-
Clinical and translational research: Linking experimental research with clinical expertise in infectious diseases.
We are interested in joining interdisciplinary consortia and contributing to the preclinical evaluation, mechanistic characterisation, and translational development of novel antiviral therapeutics.
Topic
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Irene Pérez López
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Pamplona, Spain
Project cooperation
RNA structure and viral genomics partner for antiviral discovery
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Michael Wolfinger
Founder & Principal Scientist, RNA Forecast e.U. at RNA Forecast e.U.
Vienna, Austria
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
Bhupesh Prusty
Tenured Professor at Riga Stradins University
Riga, Latvia